LAMP2 Gene Mutations And Lysosomal Dysfunction In Danon Disease
Published on: December 10, 2025
LAMP2 Gene Mutations And Lysosomal Dysfunction In Danon Disease
  • Article author photo

    Hibah Moaz

    MBiochem • Molecular and Cellular Biochemistry, University of Oxford

Introduction

Danon disease is a severe, multisystemic genetic disorder that primarily affects the heart, skeletal muscle, and nervous system. The disease was initially characterised by a distinct clinical triad: hypertrophic cardiomyopathy, skeletal myopathy, and intellectual disability. For decades, it was often misclassified as a variant of other glycogen storage diseases. However, a pivotal breakthrough came when it was discovered that the root cause was not a deficiency in a glycolytic enzyme, but rather mutations in the LAMP2 gene on the X chromosome. This finding redefined Danon disease as a unique and particularly aggressive disorder of autophagy, a fundamental cellular recycling process.

The LAMP2 gene provides instructions for making lysosomal-associated membrane protein-2 (LAMP-2), a critical component of the lysosome's membrane. The lysosome is an organelle responsible for breaking down and recycling cellular waste materials. LAMP-2 is indispensable for the final stage of autophagy, the essential process by which cells consume their own damaged components to generate energy and maintain health. Specifically, the LAMP-2B isoform is required for autophagosomes, which are vesicles that capture cellular debris and fuse with lysosomes. Without the functional form of LAMP-2, this fusion fails.

Consequently, in the case of failure, autophagic vacuoles accumulate relentlessly, particularly in muscle and heart cells, disrupting their architecture and function. This cellular crisis manifests in patients as progressive heart failure as the leading cause of death, muscle weakness, and cognitive challenges. The inheritance is X-linked dominant, meaning that while people assigned male at birth (hemizygous) are typically severely affected, people assigned female at birth (heterozygous) can also show symptoms with variable severity due to random X-chromosome inactivation.

This article will therefore explore how mutations in a single gene dismantle a critical cellular process, leading to the profound and widespread dysfunction that defines Danon disease.

The LAMP2 gene: blueprint for a key lysosomal protein 

Danon disease is caused by a mutation or change in the LAMP2 gene. Variants that lead to a complete absence of the LAMP2 protein have been shown to be the most detrimental in their prognosis. Other variants which lead to a LAMP2 protein with partial function may be less clinically severe. 

The LAMP2 gene is located on the long arm of the X chromosome (Xq24), its position immediately explains the disease’s X-linked dominant inheritance pattern. People assigned male at birth, possessing only one X chromosome, are hemizygous for the gene. Consequently, a single pathogenic mutation is sufficient to cause the complete absence of functional LAMP-2 protein, leading to the severe, classic form of the disease. People assigned female at birth, with two X chromosomes, are typically heterozygous for the mutated LAMP2 gene. This presentation is influenced by the random process of X-chromosome inactivation (lyonisation), which can lead to a mosaic expression of the mutation and a highly variable, often later-onset and attenuated disease phenotype. This means that the normal LAMP2 gene can compensate for the mutated LAMP2 gene on the other X chromosome, unlike in people assigned male at birth, who have only one X chromosome. 

The LAMP2 gene encodes lysosomal-associated membrane protein-2, one of the most abundant proteins lining the interior membrane of the lysosome. This heavy glycosylation on its large luminal domain acts as a protective barrier, shielding the lysosomal membrane from the potent hydrolytic enzymes within the organelle. Through alternative splicing of its mRNA, the single LAMP2 gene gives rise to three major protein isoforms: LAMP-2A, LAMP-2B, and LAMP-2C. While they share a common structure including a luminal domain, transmembrane anchor, and short cytoplasmic tail, each isoform has distinct and critical functions.

The LAMP-2A isoform is the central receptor for Chaperone-Mediated Autophagy (CMA), a highly selective degradation process. CMA identifies specific proteins bearing a pentapeptide motif (KFERQ), unfolds them, and translocates them directly across the lysosomal membrane into the lumen for degradation. LAMP-2A acts as the translocation channel, and its levels are the rate-limiting step in this process. In contrast, the LAMP-2B isoform is now recognised as absolutely critical for the final step of macroautophagy, the bulk degradation of large cellular components and organelles. It facilitates the fusion of autophagosomes with lysosomes, a process essential for forming the autolysosome, where degradation occurs. The function of the LAMP-2C isoform is less defined, but it is thought to play a role in other forms of selective autophagy.

The LAMP2 protein is therefore not just a structural cellular component but a master regulator of cellular cleansing, governing different pathways responsible for the turnover of proteins and organelles. A mutation in the LAMP2 gene therefore disrupts the synthesis and function of all its isoforms, crippling the cell’s degradative recycling pathways. 

From mutation to molecular disease

The pathogenesis of Danon disease is a direct result of the loss of functional LAMP-2 protein, which acts as a linchpin for lysosomal function, particularly the critical cellular recycling process of autophagy. The spectrum of mutations in the LAMP2 gene almost universally leads to a loss of function. The majority are nonsense or frameshift mutations that introduce a premature stop codon, resulting in a truncated, unstable protein that is rapidly degraded. Other mutations, such as large deletions or splice-site variants, can prevent the gene from being transcribed or translated correctly. The consequence is always the same: a critical deficiency or complete absence of the LAMP-2 protein at the lysosomal membrane. This deficiency disrupts the function of all three major isoforms (LAMP-2A, -2B, -2C), but the impact on the -2A and -2B isoforms is particularly devastating for cellular homeostasis.

The primary molecular consequence is a profound failure of autophagic flux. Without functional LAMP-2B, these autophagosomes, laden with damaged mitochondria (mitophagy), protein aggregates, and other cellular debris, cannot dock and fuse with lysosomes. They instead accumulate in the cytoplasm, unable to unload their cargo for processing. Simultaneously, the loss of the LAMP-2A isoform cripples Chaperone-Mediated Autophagy (CMA), the selective pathway for degrading specific soluble proteins. This one-two punch against both bulk and selective autophagy means the cell's primary waste disposal systems are completely shut down.

This blockade manifests histologically as the disease's hallmark: the massive accumulation of autophagic vacuoles within cells. In muscle biopsies, these are characterised as "autophagic vacuoles with sarcolemmal features," meaning they have properties of the cell membrane, a unique signature of this autophagic failure. This accumulation triggers secondary cellular dysfunction. The failure of mitophagy leads to a build-up of dysfunctional mitochondria, reducing energy production and increasing oxidative stress. The CMA blockade causes an accumulation of specific proteins that can disrupt cellular signaling. The relentless stress activates pathways leading to apoptosis (programmed cell death) and necrosis. This widespread cellular death in critical tissues—cardiac myocytes, skeletal muscle fibers, and neurons—is the direct cause of the organ dysfunction observed in patients. The heart muscle weakens and hypertrophies in a futile attempt to compensate, skeletal muscles lose their integrity and strength, and the brain suffers from the loss of neural connectivity, translating into the clinical triad of Danon disease.

Conclusion

Danon disease stands as a powerful example of monogenic pathology, where a defect in a single gene, LAMP2, unravels the essential cellular process of autophagy, leading to multisystem organ failure. The resulting catastrophic failure of cellular clearance mechanisms causes an accumulation of toxic debris, manifesting histologically as autophagic vacuoles and clinically as a relentless progression of cardiomyopathy, myopathy, and cognitive impairment. The X-linked dominant inheritance pattern dictates the severe, early-onset presentation in hemizygous people assigned male at birth and the variable, often later-onset course in heterozygous people assigned female at birth, a difference governed by the randomness of X-chromosome inactivation. Currently, management is predominantly palliative, focusing on aggressive cardiac care with medications, defibrillators, and transplantation as the only definitive intervention for heart failure. However, the very clarity of its molecular pathogenesis—a single gene defect causing a well-defined cellular dysfunction—makes Danon Disease a prime candidate for emerging targeted therapies. 

References

  1. Shalata A, Bar-Shai M, Hadid Y, Mahroum M, Mintz H, Shalata ZE, et al. Danon Disease: Entire LAMP2 Gene Deletion with Unusual Clinical Presentation-Case Report and Review of the Literature. Genes (Basel). 2023 Jul 27;14(8):1539. doi: 10.3390/genes14081539.
  2. Endo Y, Furuta A, Nishino I. Danon disease: a phenotypic expression of LAMP-2 deficiency. Acta Neuropathol. 2015 Mar;129(3):391-8. doi: 10.1007/s00401-015-1385-4.
  3. D'Souza RS, Law L. Danon Disease. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan
  4. Eskelinen EL. Roles of LAMP-1 and LAMP-2 in lysozyme biogenesis and autophagy. Mol Aspects Med. 2006;27:495-502.
  5. Boucek D, Jirikowic J, Taylor M. Natural history of Danon disease. Genet Med. 2011;13(6):563-8.
  6. Taylor MRG, Adler ED. Danon Disease. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2025 
Share

Hibah Moaz

MBiochem • Molecular and Cellular Biochemistry, University of Oxford

arrow-right